An artist's depiction of tiny magnetic nanoparticles (black) surrounding and entering cancer cells
A new study led by researchers from
University College London suggests that combining traditional chemotherapy with
an experimental therapy using magnetic nanoparticles to heat up tumor cells
could significantly enhance the efficacy of both treatments.
Researchers have known for decades that selectively
heating up tumor cells can be an effective way destroy cancer as they are
much more sensitive to heat than healthy cells. Whereas healthy cells can
withstand temperatures up to 45 °C (113 °F), cancer cells begin to die at
around 42 °C (107 °F).
To turn this knowledge
into an effective clinical treatment scientists have developed a method to
selectively heat up only targeted cancer cells. Known as magnetic hyperthermia,
the technique involves delivering magnetic particles to the site of a tumor and
then using an alternating magnetic field to selectively heat, and kill, the
specific cancer cells without harming surrounding healthy tissue.
The
method has remained mostly theoretical for years but recent advances in
nanotechnology led to the development of novel magnetic nanoparticles that
enabled the clinical realization of this treatment, which is currently
only used in humans to treat a very aggressive form of brain cancer.
While
some researchers are working to optimize these nanoparticles, making them more
efficient and effective, this new research set out to quantify the synergistic
effect of combining magnetic hyperthermia with conventional chemotherapy.
Read This Article In Hindi Click Here
In
vitro research was conducted on three different cancer cell lines (prostate,
brain and breast), testing a previously developed magnetic nanoparticle loaded
with a commonly used chemotherapy drug called doxorubicin. In all instances the
novel nanoparticle therapy destroyed more cancer cells than tests using the
chemotherapy drug alone. In the most successful experiment, the nanoparticle
therapy was 34 percent more effective at killing brain cancer cells than
doxorubicin by itself.
“Our
study shows the enormous potential of combining chemotherapy with heat treatment
delivered via magnetic nanoparticles,” says Nguyen Thanh, senior author on the
new study.
The
research suggests the combination of the two treatments generates a synergistic
effect, with each method amplifying the potency of the other. Moving forward,
Thanh says more pre-clinical work is needed to home in on the most effective
ways to deploy this novel therapy.
"While this combination of therapy is already approved for the treatment of fast-growing glioblastomas, our results suggest it has potential to be used more widely as a broad anti-cancer therapy,” says Thanh. "This therapy also has potential to reduce the side effects of chemotherapy, by ensuring it is more highly targeted on cancer cells rather than healthy tissue. This needs to be explored in further pre-clinical tests."
The
new research was published in the Journal of Materials Chemistry B.
Source: University
College London
0 Comments